Susquehanna International Group, LLP Adamis Pharmaceuticals Corp Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
BUY
$0.1 - $0.3 $812 - $2,436
8,122 Added 58.17%
22,084 $2,000
Q4 2022

Feb 14, 2023
SELL
$0.14 - $0.22 $24,200 - $38,030
-172,864 Reduced 92.53%
13,962 $2,000
Q3 2022

Nov 14, 2022
BUY
$0.24 - $0.54 $44,838 - $100,886
186,826 New
186,826 $37,000
Q1 2022

May 16, 2022
SELL
$0.55 - $0.73 $167,410 - $222,198
-304,382 Reduced 63.63%
173,979 $99,000
Q4 2021

Feb 14, 2022
SELL
$0.57 - $1.23 $512,534 - $1.11 Million
-899,184 Reduced 65.27%
478,361 $289,000
Q3 2021

Nov 15, 2021
BUY
$0.92 - $1.18 $451,393 - $578,961
490,645 Added 55.32%
1,377,545 $1.34 Million
Q2 2021

Aug 11, 2021
BUY
$0.66 - $1.23 $80,224 - $149,510
121,553 Added 15.88%
886,900 $976,000
Q1 2021

May 17, 2021
BUY
$0.54 - $1.79 $266,609 - $883,760
493,721 Added 181.77%
765,347 $719,000
Q4 2020

Feb 16, 2021
BUY
$0.4 - $1.01 $3,156 - $7,969
7,891 Added 2.99%
271,626 $132,000
Q3 2020

Nov 16, 2020
BUY
$0.52 - $1.45 $130,901 - $365,012
251,733 Added 2097.43%
263,735 $207,000
Q2 2020

Aug 14, 2020
SELL
$0.33 - $0.66 $2,709 - $5,418
-8,210 Reduced 40.62%
12,002 $6,000
Q1 2020

May 15, 2020
BUY
$0.33 - $0.89 $2,270 - $6,123
6,880 Added 51.61%
20,212 $7,000
Q4 2019

Feb 14, 2020
SELL
$0.51 - $1.26 $19,099 - $47,187
-37,450 Reduced 73.75%
13,332 $9,000
Q3 2019

Nov 14, 2019
SELL
$0.7 - $1.46 $48,070 - $100,261
-68,672 Reduced 57.49%
50,782 $36,000
Q2 2019

Aug 16, 2019
BUY
$1.26 - $2.23 $3,413 - $6,041
2,709 Added 2.32%
119,454 $155,000
Q2 2019

Aug 14, 2019
SELL
$1.26 - $2.23 $91,395 - $161,755
-72,536 Reduced 38.32%
116,745 $152,000
Q1 2019

May 15, 2019
BUY
$2.02 - $3.22 $202,333 - $322,531
100,165 Added 112.4%
189,281 $399,000
Q4 2018

Feb 14, 2019
SELL
$2.1 - $3.21 $1.11 Million - $1.69 Million
-527,191 Reduced 85.54%
89,116 $201,000
Q3 2018

Nov 14, 2018
BUY
$2.25 - $4.8 $1.21 Million - $2.59 Million
539,410 Added 701.47%
616,307 $2.16 Million
Q2 2018

Aug 14, 2018
SELL
$3.2 - $4.7 $60,003 - $88,129
-18,751 Reduced 19.6%
76,897 $246,000
Q1 2018

May 15, 2018
SELL
$2.55 - $4.85 $690,167 - $1.31 Million
-270,654 Reduced 73.89%
95,648 $335,000
Q4 2017

Feb 14, 2018
BUY
$3.5 - $5.65 $20,384 - $32,905
5,824 Added 1.62%
366,302 $1.61 Million
Q3 2017

Nov 14, 2017
BUY
$4.5 - $5.65 $1.62 Million - $2.04 Million
360,478
360,478 $1.88 Million

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email